EU centralized/decentralized procedures for devices: likely outlook now?
This article was originally published in Clinica
Executive Summary
The involvement of the European Medicines Agency in the future EU regulation of medical devices and diagnostics would be a Herculean task with huge financial and organizational issues. That was the view expressed by MEPs Dr Peter Liese and Rebecca Taylor last week at the European Parliament in Brussels.